Safety considerations with the use of platelet inhibitors for elderly patients with non-ST- elevation acute coronary syndrome.

Expert Opinion on Drug Safety
M E Gimbel, J M Ten Berg

Abstract

Introduction: Dual antiplatelet therapy (DAPT) is standard treatment for patients with acute coronary syndrome (ACS). This includes lifelong aspirin combined with a P2Y12 inhibitor for 1 year. The indication for one of the P2Y12 inhibitors (clopidogrel, prasugrel, ticagrelor) is dependent on the treatment strategy; whether patients undergo coronary angiography or are treated medically only. Tailoring antiplatelet therapy to the risk profile of the individual patient is of specific importance to the older patient.Areas covered: In this review, we discuss dual antiplatelet therapy in elderly patients with ACS. We present the options to tailor antiplatelet therapy based on platelet function testing, CYP2C19 genotyping and patients' thrombotic and bleeding risk. Finally, we discuss alternatives for dual antiplatelet therapy.Expert opinion: DAPT in elderly patients with ACS should consist of aspirin with clopidogrel or ticagrelor. Weighing patients' thrombotic and bleeding risk, based on clinical judgment or with use of specific risk scores, is probably the most convenient method to individualize antiplatelet therapy; however, CYP2C19 genotyping can also be used. In elderly patients with an increased bleeding risk, clopidogrel is a ...Continue Reading

References

Aug 25, 2001·The New England Journal of Medicine·S YusufUNKNOWN Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
Feb 7, 2002·European Journal of Clinical Pharmacology·W J TammingaJ H Jonkman
Jun 28, 2002·The New England Journal of Medicine·Kam Chuen LaiJohn Wong
Nov 6, 2007·The New England Journal of Medicine·Stephen D WiviottUNKNOWN TRITON-TIMI 38 Investigators
Aug 27, 2009·Nature Reviews. Cardiology·Naveen L Pereira, Richard M Weinshilboum
Sep 1, 2009·The New England Journal of Medicine·Lars WallentinMona Thorsén
Oct 12, 2010·The New England Journal of Medicine·Deepak L BhattUNKNOWN COGENT Investigators
Nov 13, 2010·Journal of the American College of Cardiology·Davide Capodanno, Dominick J Angiolillo
Aug 28, 2012·The New England Journal of Medicine·Matthew T RoeUNKNOWN TRILOGY ACS Investigators
Jan 16, 2013·Thrombosis·Thea Cornelia GodschalkJurriën Maria Ten Berg
May 24, 2013·Clinical Pharmacology and Therapeutics·S A ScottUNKNOWN Clinical Pharmacogenetics Implementation Consortium
Nov 18, 2014·The New England Journal of Medicine·Laura MauriUNKNOWN DAPT Study Investigators
Jul 15, 2015·European Heart Journal·Felicita AndreottiUNKNOWN ESC Thrombosis Working Group
Sep 1, 2015·Journal of the American College of Cardiology·Philippe GénéreuxGregg W Stone
Mar 30, 2016·JAMA : the Journal of the American Medical Association·Robert W YehUNKNOWN DAPT Study Investigators
Aug 9, 2016·International Journal of Cardiology·Lina BadimonJudit Cubedo
Apr 30, 2017·American Heart Journal·Gregory DucrocqPhilippe Gabriel Steg
Feb 16, 2018·European Heart Journal·Giovanni G Camici, Luca Liberale
Apr 19, 2019·Circulation. Cardiovascular Interventions·Naveen L PereiraMichael E Farkouh
Sep 3, 2019·The New England Journal of Medicine·Stefanie SchüpkeUNKNOWN ISAR-REACT 5 Trial Investigators
Sep 4, 2019·The New England Journal of Medicine·Daniel M F ClaassensJurriën M Ten Berg
Sep 21, 2019·Journal of the American Heart Association·Piera Capranzano, Dominick J Angiolillo
Sep 27, 2019·The New England Journal of Medicine·Roxana MehranC Michael Gibson
Dec 18, 2019·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Mariusz TomaniakPatrick W Serruys

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cardiology and Therapy
Raghav SharmaYogesh Belagali
JAMA : the Journal of the American Medical Association
Hassan KamranUmair Khalid
Expert Review of Cardiovascular Therapy
Johanne SilvainGilles Montalescot
European Heart Journal Supplements : Journal of the European Society of Cardiology
Giulia Masiero, Roberta Rossini
The Journal of the Association of Physicians of India
Immaneni SathyamurthySwami Onkar C
© 2021 Meta ULC. All rights reserved